カテゴリ： LP Information, 世界, 医療/バイオ

吸入式新型コロナウイルス感染症ワクチンの世界市場2022-2028：18～30歳、30歳以上

■ 英語タイトル：Global Inhaled COVID-19 Vaccine Market Growth 2022-2028

調査会社LP Information社が発行したリサーチレポート（データ管理コード：LP22DC4628）■ 発行会社/調査会社：LP Information
■ 商品コード：LP22DC4628
■ 発行日：2022年12月
■ 調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
■ 産業分野：医療機器
■ ページ数：73
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※LP Information社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[吸入式新型コロナウイルス感染症ワクチンの世界市場2022-2028：18～30歳、30歳以上]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

吸入式新型コロナウイルス感染症ワクチンのグローバル市場規模は、2021年のxxx百万ドルから2028年までにxxx百万ドルに増加すると推定されており、2022年～2028年の年平均成長率（CAGR）はxx%を示しています。COVID-19とロシア・ウクライナ戦争の不確実性を念頭に置いて、さまざまな最終用途部門に対するパンデミックの直接的および間接的な影響を継続的に追跡・分析しています。これらのインサイトは、主要な市場要因としてレポートに含まれています。
吸入式新型コロナウイルス感染症ワクチンのアジア太平洋市場は、2022年にxxx百万ドルの市場規模が見込まれ、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。吸入式新型コロナウイルス感染症ワクチンの米国市場は、2022年にxxx百万ドルの規模があり、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。吸入式新型コロナウイルス感染症ワクチンのヨーロッパ市場は、2022年にxxx百万ドルの規模が見込まれ、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。吸入式新型コロナウイルス感染症ワクチンの中国市場は、2022年にxxx百万ドルの規模があり、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。

世界の主要な吸入式新型コロナウイルス感染症ワクチン関連企業としては、CanSino Biologicsなどをカバーしています。売上の面では世界最大の2社が2021年にほぼxx%の市場シェアを占めています。

*** レポート範囲 ***

この最新のレポートはすべての重要な側面をカバーしながら吸入式新型コロナウイルス感染症ワクチンのグローバル市場に関する深いインサイトを提供します。これは、市場のマクロな概要から、市場規模、競争環境、開発動向、ニッチ市場、主要な市場ドライバーと課題、バリュー チェーン分析などのミクロの詳細にまで及びます。当レポートは読者がパンデミックおよびロシア・ウクライナ戦争中に世界中で吸入式新型コロナウイルス感染症ワクチン市場シナリオがどのように変化したかを理解できるように定量的データと定性的データの両方を使用して、吸入式新型コロナウイルス感染症ワクチンのグローバル市場の全体像を提供することを目的としています。

分析の対象となる基準年は2021年で、市場の予測は2022年～2028年までのものです。

*** 市場セグメンテーション ***

この調査では吸入式新型コロナウイルス感染症ワクチン市場を細分化し、種類別 (18～30歳、30歳以上)、用途別 (医療、研究)、および地域別 (アジア太平洋、アメリカ州、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：18～30歳、30歳以上

・用途別区分：医療、研究

・地域別区分
アメリカ州（アメリカ、カナダ、メキシコ、ブラジル）
APAC/アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

*** 各章の紹介 ***
第1章：吸入式新型コロナウイルス感染症ワクチンの範囲、調査方法など
第2章：エグゼクティブサマリー、世界の吸入式新型コロナウイルス感染症ワクチン市場規模 (販売量、売上) およびCAGR、地域別・種類別・用途別、2017年～2022年までの推移データ、および2028年までの市場予測
第3章：企業別吸入式新型コロナウイルス感染症ワクチンの販売量、売上、平均価格、グローバル市場シェア、および業界ランキング
第4章：地域別および国別の吸入式新型コロナウイルス感染症ワクチンの販売量と売上（米国、カナダ、ヨーロッパ、中国、日本、韓国、東南アジア、インド、ラテンアメリカ、中東・アフリカなど）
第5/6/7/8章：アメリカ州、アジア太平洋、ヨーロッパ、中東・アフリカの国別、種類別の販売セグメント
第9章：市場動向、市場予測、機会、将来の市場に影響を与える経済動向の分析
第10章：製造コスト構造分析
第11章：販売チャンネル、販売業者および顧客
第12章：地域別、国別、種類別、用途別の世界の吸入式新型コロナウイルス感染症ワクチン市場規模予測
第13章：主要企業の包括的な企業プロファイル
第14章：調査の結果

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：吸入式新型コロナウイルス感染症ワクチンの年間販売量2017-2028、地域別現状・将来分析
・吸入式新型コロナウイルス感染症ワクチンの種類別セグメント：18～30歳、30歳以上
・吸入式新型コロナウイルス感染症ワクチンの種類別販売量：2017-2022年の販売量、売上、市場シェア、販売価格
・吸入式新型コロナウイルス感染症ワクチンの用途別セグメント：医療、研究
・吸入式新型コロナウイルス感染症ワクチンの用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格

企業別世界の吸入式新型コロナウイルス感染症ワクチン市場
・企業別のグローバル吸入式新型コロナウイルス感染症ワクチン市場データ：2020-2022年の年間販売量、市場シェア
・企業別の吸入式新型コロナウイルス感染症ワクチンの年間売上：2020-2022年の売上、市場シェア
・企業別の吸入式新型コロナウイルス感染症ワクチン販売価格
・主要企業の吸入式新型コロナウイルス感染症ワクチン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

吸入式新型コロナウイルス感染症ワクチンの地域別レビュー
・地域別の吸入式新型コロナウイルス感染症ワクチン市場規模2017-2022：年間販売量、売上
・主要国別の吸入式新型コロナウイルス感染症ワクチン市場規模2017-2022：年間販売量、売上
・アメリカ州の吸入式新型コロナウイルス感染症ワクチン販売の成長
・アジア太平洋の吸入式新型コロナウイルス感染症ワクチン販売の成長
・ヨーロッパの吸入式新型コロナウイルス感染症ワクチン販売の成長
・中東・アフリカの吸入式新型コロナウイルス感染症ワクチン販売の成長

アメリカ州市場
・アメリカ州の国別の吸入式新型コロナウイルス感染症ワクチン販売量、売上（2017-2022）
・アメリカ州の吸入式新型コロナウイルス感染症ワクチンの種類別販売量
・アメリカ州の吸入式新型コロナウイルス感染症ワクチンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋（APAC）市場
・アジア太平洋の国別の吸入式新型コロナウイルス感染症ワクチン販売量、売上（2017-2022）
・アジア太平洋の吸入式新型コロナウイルス感染症ワクチンの種類別販売量
・アジア太平洋の吸入式新型コロナウイルス感染症ワクチンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の吸入式新型コロナウイルス感染症ワクチン販売量、売上（2017-2022）
・ヨーロッパの吸入式新型コロナウイルス感染症ワクチンの種類別販売量
・ヨーロッパの吸入式新型コロナウイルス感染症ワクチンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の吸入式新型コロナウイルス感染症ワクチン販売量、売上（2017-2022）
・中東・アフリカの吸入式新型コロナウイルス感染症ワクチンの種類別販売量
・中東・アフリカの吸入式新型コロナウイルス感染症ワクチンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・吸入式新型コロナウイルス感染症ワクチンの製造コスト構造分析
・吸入式新型コロナウイルス感染症ワクチンの製造プロセス分析
・吸入式新型コロナウイルス感染症ワクチンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・吸入式新型コロナウイルス感染症ワクチンの主要なグローバル販売業者
・吸入式新型コロナウイルス感染症ワクチンの主要なグローバル顧客

地域別の吸入式新型コロナウイルス感染症ワクチン市場予測レビュー
・地域別の吸入式新型コロナウイルス感染症ワクチン市場規模予測（2023-2028）
・アメリカ州の国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・吸入式新型コロナウイルス感染症ワクチンの種類別市場規模予測
・吸入式新型コロナウイルス感染症ワクチンの用途別市場規模予測

主要企業分析
CanSino Biologics
・企業情報
・吸入式新型コロナウイルス感染症ワクチン製品
・吸入式新型コロナウイルス感染症ワクチン販売量、売上、価格、粗利益（2020-2022）
・主要ビジネス概要
・最新動向

調査の結果

The global market for Inhaled COVID-19 Vaccine is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Inhaled COVID-19 Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Inhaled COVID-19 Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Inhaled COVID-19 Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Inhaled COVID-19 Vaccine market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Inhaled COVID-19 Vaccine players cover CanSino Biologics… etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

[Report Coverage]
This latest report provides a deep insight into the global Inhaled COVID-19 Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Inhaled COVID-19 Vaccine market, with both quantitative and qualitative data, to help readers understand how the Inhaled COVID-19 Vaccine market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Units.

[Market Segmentation]
The study segments the Inhaled COVID-19 Vaccine market and forecasts the market size by Type (18-30 Years Old and 30 Years Old and Above,), by Application (Medical and Research.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
18-30 Years Old
30 Years Old and Above
Segmentation by application
Medical
Research
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
CanSino Biologics

[Chapter Introduction]
Chapter 1: Scope of Inhaled COVID-19 Vaccine, Research Methodology, etc.
Chapter 2: Executive Summary, global Inhaled COVID-19 Vaccine market size (sales and revenue) and CAGR, Inhaled COVID-19 Vaccine market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Inhaled COVID-19 Vaccine sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Inhaled COVID-19 Vaccine sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Inhaled COVID-19 Vaccine market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including CanSino Biologics. etc.
Chapter 14: Research Findings and Conclusion

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Inhaled COVID-19 Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Inhaled COVID-19 Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Inhaled COVID-19 Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Inhaled COVID-19 Vaccine Segment by Type
2.2.1 18-30 Years Old
2.2.2 30 Years Old and Above
2.3 Inhaled COVID-19 Vaccine Sales by Type
2.3.1 Global Inhaled COVID-19 Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Inhaled COVID-19 Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Inhaled COVID-19 Vaccine Sale Price by Type (2017-2022)
2.4 Inhaled COVID-19 Vaccine Segment by Application
2.4.1 Medical
2.4.2 Research
2.5 Inhaled COVID-19 Vaccine Sales by Application
2.5.1 Global Inhaled COVID-19 Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Inhaled COVID-19 Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Inhaled COVID-19 Vaccine Sale Price by Application (2017-2022)
3 Global Inhaled COVID-19 Vaccine by Company
3.1 Global Inhaled COVID-19 Vaccine Breakdown Data by Company
3.1.1 Global Inhaled COVID-19 Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Inhaled COVID-19 Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Inhaled COVID-19 Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Inhaled COVID-19 Vaccine Revenue by Company (2020-2022)
3.2.2 Global Inhaled COVID-19 Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Inhaled COVID-19 Vaccine Sale Price by Company
3.4 Key Manufacturers Inhaled COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhaled COVID-19 Vaccine Product Location Distribution
3.4.2 Players Inhaled COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Inhaled COVID-19 Vaccine by Geographic Region
4.1 World Historic Inhaled COVID-19 Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Inhaled COVID-19 Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Inhaled COVID-19 Vaccine Annual Revenue by Geographic Region
4.2 World Historic Inhaled COVID-19 Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Inhaled COVID-19 Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Inhaled COVID-19 Vaccine Annual Revenue by Country/Region
4.3 Americas Inhaled COVID-19 Vaccine Sales Growth
4.4 APAC Inhaled COVID-19 Vaccine Sales Growth
4.5 Europe Inhaled COVID-19 Vaccine Sales Growth
4.6 Middle East & Africa Inhaled COVID-19 Vaccine Sales Growth
5 Americas
5.1 Americas Inhaled COVID-19 Vaccine Sales by Country
5.1.1 Americas Inhaled COVID-19 Vaccine Sales by Country (2017-2022)
5.1.2 Americas Inhaled COVID-19 Vaccine Revenue by Country (2017-2022)
5.2 Americas Inhaled COVID-19 Vaccine Sales by Type
5.3 Americas Inhaled COVID-19 Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhaled COVID-19 Vaccine Sales by Region
6.1.1 APAC Inhaled COVID-19 Vaccine Sales by Region (2017-2022)
6.1.2 APAC Inhaled COVID-19 Vaccine Revenue by Region (2017-2022)
6.2 APAC Inhaled COVID-19 Vaccine Sales by Type
6.3 APAC Inhaled COVID-19 Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Inhaled COVID-19 Vaccine by Country
7.1.1 Europe Inhaled COVID-19 Vaccine Sales by Country (2017-2022)
7.1.2 Europe Inhaled COVID-19 Vaccine Revenue by Country (2017-2022)
7.2 Europe Inhaled COVID-19 Vaccine Sales by Type
7.3 Europe Inhaled COVID-19 Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Inhaled COVID-19 Vaccine by Country
8.1.1 Middle East & Africa Inhaled COVID-19 Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Inhaled COVID-19 Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Inhaled COVID-19 Vaccine Sales by Type
8.3 Middle East & Africa Inhaled COVID-19 Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhaled COVID-19 Vaccine
10.3 Manufacturing Process Analysis of Inhaled COVID-19 Vaccine
10.4 Industry Chain Structure of Inhaled COVID-19 Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhaled COVID-19 Vaccine Distributors
11.3 Inhaled COVID-19 Vaccine Customer
12 World Forecast Review for Inhaled COVID-19 Vaccine by Geographic Region
12.1 Global Inhaled COVID-19 Vaccine Market Size Forecast by Region
12.1.1 Global Inhaled COVID-19 Vaccine Forecast by Region (2023-2028)
12.1.2 Global Inhaled COVID-19 Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Inhaled COVID-19 Vaccine Forecast by Type
12.7 Global Inhaled COVID-19 Vaccine Forecast by Application
13 Key Players Analysis
13.1 CanSino Biologics
13.1.1 CanSino Biologics Company Information
13.1.2 CanSino Biologics Inhaled COVID-19 Vaccine Product Offered
13.1.3 CanSino Biologics Inhaled COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CanSino Biologics Main Business Overview
13.1.5 CanSino Biologics Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Inhaled COVID-19 Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Inhaled COVID-19 Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 18-30 Years Old
Table 4. Major Players of 30 Years Old and Above
Table 5. Global Inhaled COVID-19 Vaccine Sales by Type (2017-2022) & (Units)
Table 6. Global Inhaled COVID-19 Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Inhaled COVID-19 Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Inhaled COVID-19 Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Inhaled COVID-19 Vaccine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Inhaled COVID-19 Vaccine Sales by Application (2017-2022) & (Units)
Table 11. Global Inhaled COVID-19 Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Inhaled COVID-19 Vaccine Revenue by Application (2017-2022)
Table 13. Global Inhaled COVID-19 Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Inhaled COVID-19 Vaccine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Inhaled COVID-19 Vaccine Sales by Company (2020-2022) & (Units)
Table 16. Global Inhaled COVID-19 Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Inhaled COVID-19 Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Inhaled COVID-19 Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Inhaled COVID-19 Vaccine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Inhaled COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 21. Players Inhaled COVID-19 Vaccine Products Offered
Table 22. Inhaled COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Inhaled COVID-19 Vaccine Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Inhaled COVID-19 Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Inhaled COVID-19 Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Inhaled COVID-19 Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Inhaled COVID-19 Vaccine Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Inhaled COVID-19 Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Inhaled COVID-19 Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Inhaled COVID-19 Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Inhaled COVID-19 Vaccine Sales by Country (2017-2022) & (Units)
Table 34. Americas Inhaled COVID-19 Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Inhaled COVID-19 Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Inhaled COVID-19 Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Inhaled COVID-19 Vaccine Sales by Type (2017-2022) & (Units)
Table 38. Americas Inhaled COVID-19 Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Inhaled COVID-19 Vaccine Sales by Application (2017-2022) & (Units)
Table 40. Americas Inhaled COVID-19 Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Inhaled COVID-19 Vaccine Sales by Region (2017-2022) & (Units)
Table 42. APAC Inhaled COVID-19 Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Inhaled COVID-19 Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Inhaled COVID-19 Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Inhaled COVID-19 Vaccine Sales by Type (2017-2022) & (Units)
Table 46. APAC Inhaled COVID-19 Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Inhaled COVID-19 Vaccine Sales by Application (2017-2022) & (Units)
Table 48. APAC Inhaled COVID-19 Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Inhaled COVID-19 Vaccine Sales by Country (2017-2022) & (Units)
Table 50. Europe Inhaled COVID-19 Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Inhaled COVID-19 Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Inhaled COVID-19 Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Inhaled COVID-19 Vaccine Sales by Type (2017-2022) & (Units)
Table 54. Europe Inhaled COVID-19 Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Inhaled COVID-19 Vaccine Sales by Application (2017-2022) & (Units)
Table 56. Europe Inhaled COVID-19 Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Inhaled COVID-19 Vaccine Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Inhaled COVID-19 Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Inhaled COVID-19 Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Inhaled COVID-19 Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Inhaled COVID-19 Vaccine Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Inhaled COVID-19 Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Inhaled COVID-19 Vaccine Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Inhaled COVID-19 Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Inhaled COVID-19 Vaccine
Table 66. Key Market Challenges & Risks of Inhaled COVID-19 Vaccine
Table 67. Key Industry Trends of Inhaled COVID-19 Vaccine
Table 68. Inhaled COVID-19 Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Inhaled COVID-19 Vaccine Distributors List
Table 71. Inhaled COVID-19 Vaccine Customer List
Table 72. Global Inhaled COVID-19 Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Inhaled COVID-19 Vaccine Sales Market Forecast by Region
Table 74. Global Inhaled COVID-19 Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Inhaled COVID-19 Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Inhaled COVID-19 Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Inhaled COVID-19 Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Inhaled COVID-19 Vaccine Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Inhaled COVID-19 Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Inhaled COVID-19 Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Inhaled COVID-19 Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Inhaled COVID-19 Vaccine Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Inhaled COVID-19 Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Inhaled COVID-19 Vaccine Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Inhaled COVID-19 Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Inhaled COVID-19 Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Inhaled COVID-19 Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Inhaled COVID-19 Vaccine Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Inhaled COVID-19 Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Inhaled COVID-19 Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Inhaled COVID-19 Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. CanSino Biologics Basic Information, Inhaled COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. CanSino Biologics Inhaled COVID-19 Vaccine Product Offered
Table 94. CanSino Biologics Inhaled COVID-19 Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. CanSino Biologics Main Business
Table 96. CanSino Biologics Latest Developments
List of Figures
Figure 1. Picture of Inhaled COVID-19 Vaccine
Figure 2. Inhaled COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhaled COVID-19 Vaccine Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Inhaled COVID-19 Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Inhaled COVID-19 Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 18-30 Years Old
Figure 10. Product Picture of 30 Years Old and Above
Figure 11. Global Inhaled COVID-19 Vaccine Sales Market Share by Type in 2021
Figure 12. Global Inhaled COVID-19 Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Inhaled COVID-19 Vaccine Consumed in Medical
Figure 14. Global Inhaled COVID-19 Vaccine Market: Medical (2017-2022) & (Units)
Figure 15. Inhaled COVID-19 Vaccine Consumed in Research
Figure 16. Global Inhaled COVID-19 Vaccine Market: Research (2017-2022) & (Units)
Figure 17. Global Inhaled COVID-19 Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Inhaled COVID-19 Vaccine Revenue Market Share by Application in 2021
Figure 19. Inhaled COVID-19 Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Inhaled COVID-19 Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Inhaled COVID-19 Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Inhaled COVID-19 Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Inhaled COVID-19 Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Inhaled COVID-19 Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Inhaled COVID-19 Vaccine Sales 2017-2022 (Units)
Figure 26. Americas Inhaled COVID-19 Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Inhaled COVID-19 Vaccine Sales 2017-2022 (Units)
Figure 28. APAC Inhaled COVID-19 Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Inhaled COVID-19 Vaccine Sales 2017-2022 (Units)
Figure 30. Europe Inhaled COVID-19 Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Inhaled COVID-19 Vaccine Sales 2017-2022 (Units)
Figure 32. Middle East & Africa Inhaled COVID-19 Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Inhaled COVID-19 Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Inhaled COVID-19 Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Inhaled COVID-19 Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Inhaled COVID-19 Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Inhaled COVID-19 Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Inhaled COVID-19 Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Inhaled COVID-19 Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Inhaled COVID-19 Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Inhaled COVID-19 Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Inhaled COVID-19 Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Inhaled COVID-19 Vaccine
Figure 63. Industry Chain Structure of Inhaled COVID-19 Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

※関連データはありません。

※注目の調査資料
 ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(LP22DC4628 )"吸入式新型コロナウイルス感染症ワクチンの世界市場2022-2028：18～30歳、30歳以上" (英文：Global Inhaled COVID-19 Vaccine Market Growth 2022-2028)はLP Information社が調査・発行しており、H&Iグローバルリサーチが販売します。

◆H&Iグローバルリサーチのお客様（例）◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。